The latest Fortune 500 list of the largest U.S. corporations, based on 2012 total revenue, includes 13 pharmaceutical firms. The largest pharma companies with their overall rank [within brackets] on this year’s Fortune 500 list were:
- Johnson & Johnson [41]
- Pfizer [48]
- Merck [58]
- Abbott Laboratories [70]
- Eli Lilly [130]
- Bristol-Myers Squibb [158]
- Amgen [162]
- Gilead Sciences [280]
- Mylan [374]
- Actavis [432]
- Allergan [440]
- Biogen Idec [454]
- Celgene [456]
The following financial data is available for each listed corporation: total revenue, total profit, assets, number of employees, total stockholder’s equity, total return to investors, earnings per share, profit as a percent of revenue, profit as a percent of assets, and profit as a percent of stockholder’s equity.
Earlier rankings can also be viewed online back to 2006. For last year’s ranking, see https://aharesourcecenter.wordpress.com/2012/05/22/largest-u-s-pharmaceutical-companies-by-2011-revenue/
Source: Fortune 500 – Pharmaceuticals. CNNMoney, May 6, 2013. http://money.cnn.com/magazines/fortune/fortune500/2013/full_list/
Posted by AHA Resource Center, (312) 422-2050, rc@aha.org
Filed under: Pharmaceuticals, Posted by Diana Culbertson | Tagged: biggest drug companies, largest pharmaceutical companies, pharmaceutical company rankings by revenue |
American Hospital Association Resource Center Blog 
[…] see later post updated […]